Profile photo Rik Verheijden

Rik Verheijden

PHD Candidate - OIO

Strategic program(s):

Recent publications

BRAF/MEK inhibitor rechallenge in advanced melanoma patients Olivier J Van Not, Alfons J M van den Eertwegh, John B Haanen, Rozemarijn S van Rijn, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, Marye J Boers-Sonderen, Jan Willem W B de Groot, Geke AP Hospers, Ellen Kapiteijn, Manja Bloem, Djura Piersma, Marion Stevense-den Boer, Rik J Verheijden, Astrid A M van der Veldt, Michel W J M Wouters, Willeke A M Blokx, Karijn P M Suijkerbuijk
Cancer, 2024, vol. 130, p.1673-1683
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma Rik J. Verheijden, Femke H. Burgers, Josephine C. Janssen, Anouk E. Putker, Sophie P.G.R. Veenstra, Geke A.P. Hospers, Maureen J.B. Aarts, Karel W. Hehenkamp, Veerle L.E. Doornebosch, Marthe Verhaert, Franchette W.P.J. van den Berkmortel, Katerina Chatzidionysiou, Arturo Llobell, Milton Barros, Alexandre T.J. Maria, Akari Takeji, José Salvador García Morillo, Merav Lidar, Mick J.M. van Eijs, Christian U. Blank, Sandrine Aspeslagh, Djura Piersma, Ellen Kapiteijn, Mariette Labots, Marye J. Boers-Sonderen, Astrid A.M. van der Veldt, John B.A.G. Haanen, Anne M. May, Karijn P.M. Suijkerbuijk
European Journal of Cancer, 2024, vol. 207
A prediction model for response to immune checkpoint inhibition in advanced melanoma Isabella A J van Duin, Rik J Verheijden, Paul J van Diest, Willeke A M Blokx, Mary-Ann El-Sharouni, Joost J C Verhoeff, Tim Leiner, Alfonsus J M van den Eertwegh, Jan Willem B de Groot, Olivier J van Not, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, John B A G Haanen, Geke A P Hospers, Djura Piersma, Rozemarijn S van Rijn, Astrid A M van der Veldt, Gerard Vreugdenhil, Michel W J M Wouters, Marion A M Stevense-den Boer, Marye J Boers-Sonderen, Ellen Kapiteijn, Karijn P M Suijkerbuijk, Sjoerd G Elias
International Journal of Cancer, 2024, vol. 154, p.1760-1771
Prognostic value of Lynch syndrome, BRAF V600E, and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts. Koen Zwart, Frederieke H van der Baan, Romain Cohen, Thomas Aparicio, Christelle de la Fouchardiére, Thierry Lecomte, Cornelis J A Punt, David Sefrioui, Rik J Verheijden, Geraldine R Vink, G Emerens Wensink, Aziz Zaanan, Miriam Koopman, David Tougeron, Jeanine M L Roodhart
Cancer Medicine, 2023, vol. 12, p.15841-15853
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma Isabella A.J. van Duin, Sjoerd G. Elias, Alfonsus J.M. van den Eertwegh, Jan Willem B. de Groot, Willeke A.M. Blokx, Paul J. van Diest, Tim Leiner, Joost J.C. Verhoeff, Rik J. Verheijden, Olivier J. van Not, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Christian U. Blank, John B.A.G. Haanen, Geke A.P. Hospers, Anna M. Kamphuis, Djura Piersma, Rozemarijn S. van Rijn, Astrid A.M. van der Veldt, Gerard Vreugdenhil, Michel W.J.M. Wouters, Marion A.M. Stevense-den Boer, Marye J. Boers-Sonderen, Ellen Kapiteijn, Karijn P.M. Suijkerbuijk
International Journal of Cancer, 2023, vol. 152, p.2493-2502
Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis Mick J.M. van Eijs, José J.M. ter Linde, Matthijs J.D. Baars, Mojtaba Amini, Miangela M. Laclé, Eelco C. Brand, Eveline M. Delemarre, Julia Drylewicz, Stefan Nierkens, Rik J. Verheijden, Bas Oldenburg, Yvonne Vercoulen, Karijn P.M. Suijkerbuijk, Femke van Wijk
iScience, 2023, vol. 26

Fellowships & Awards

2023: ESMO Merit Award

2018: ESMO Merit Award